Agios Pharmaceuticals Says FDA Has Not Issued Decision On Agios' sNDA for Mitapivat
I'm PortAI, I can summarize articles.
Dec 8 (Reuters) - Agios Pharmaceuticals Inc:AGIOS PROVIDES UPDATE ON U.S. SNDA FOR MITAPIVAT IN THALASSEMIAAGIOS PHARMACEUTICALS INC - FDA HAS NOT ISSUED DECISION ON AGIOS’ SNDA FOR MITAPIVATAGIOS PHARMACEUTICALS INC - COLLABORATING WITH FDA ON LABELING AND REMS MATERIALS FOR FOR MITAPIVATAGIOS PHARMACEUTICALS INC - FDA HAS NOT REQUESTED NEW EFFICACY OR SAFETY DATAAGIOS PHARMACEUTICALS INC - FDA HAS NOT PROVIDED TIMELINE FOR REGULATORY DECISION Source text: Further company coverage:
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments